Back to FMR LLC FMR LLC

DICEDICE
9 quarters

Position history for FMR LLCFMR LLC's holdings in DICE THERAPEUTICS INC

As of its Q2 2023 13F, FMR held 2,239,223 shares of DICE (Dice Therapeutics), worth $104M. FMR's 13F filings listed DICE from Q3 2021 to Q2 2023, 8 quarterly filings.

Final Value

$0

Final Shares

0

Total Value Change

-$31.6M

Total Shares Change

-964,500

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2023-Q3
Latest
Exited
0
-100.0%
$00.0%—
0
2023-Q2
Decreased
2.2M
-60.6%
$104M0.0%—
0
2023-Q1
Increased
5.7M
+9.3%
$162.7M0.0%—
33
2022-Q4
Increased
5.2M
+51.8%
$162.2M0.0%—
42
2022-Q3
Increased
3.4M
+79.2%
$69.4M0.0%—
45
2022-Q2
Increased
1.9M
+460.0%
$29.6M0.0%—
46
2022-Q1
Decreased
341,122
-13.1%
$6.5M0.0%—
0
2021-Q4
Decreased
392,600
-59.3%
$9.9M0.0%—
0
2021-Q3
New
964,500
-
$31.6M0.0%—
40

Other major holders of DICE: RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used